2002年1月1日 · The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug Monitoring.

The primary aims of pharmacovigilance include: Detecting ADRs (Adverse Drug Reactions) : Early detection of adverse drug reactions that may not have been identified during clinical trials. Ensuring drug safety : Assessing the risks and benefits of drugs in real-world settings to ensure that patients are not harmed by potentially dangerous drugs.

Pharmacovigilance (PV, or PhV), also known as drug safety, is the pharmaceutical science relating to the "collection, detection, assessment, monitoring, and prevention" of adverse effects with pharmaceutical products. [1]: 7.

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem. All medicines and vaccines undergo rigorous testing for safety and efficacy through clinical trials before they are authorized for use.

2018年7月3日 · The World Health Organization (WHO) defines pharmacovigilance as “the science of collecting, monitoring, researching, assessing and evaluating information from healthcare providers and patients on the adverse effects of medications and biologics.” Also, according to WHO, pharmacovigilance has four principal aims, they are, improve patient ...

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The European Medicines Agency (EMA) coordinates the European Union (EU) pharmacovigilance system and operates services and processes to support pharmacovigilance in the EU.

2021年12月1日 · Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. It is an essential component of patient care and rational use of medicines.

2022年12月31日 · Pharmacovigilance aims to preserve general health by identifying, evaluating, and minimizing health issues to ensure that the benefits of accessible treatments outweigh the potential risks.

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicinal products related problem. WHO hosts the WHO Programme for International Drug Monitoring and supports countries to strengthen Pharmacovigilance collaboration with partners.

Specific aims of pharmacovigilance are to: Maintain a robust monitoring system for new safety issues. Implement effective approaches to minimise risk. Improve patient care and safety in relation to the use of medicines and all medical and paramedical (services that support medical work, such as nursing, first aid, radiography) interventions.